Bioengineered Allogeneic Immune Cells (AlloStim) Not Requiring HLA Donor Match for Blood Cancers

NCT00861965 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

TERMINATED

Status

2

Enrollment

INDUSTRY

Sponsor class

Stopped withdrawn due to poor recruitment

Conditions

Advanced or Refractory Leukemia, Lymphoma, Multiple Myeloma

Interventions

BIOLOGICAL: AlloStim-8
BIOLOGICAL: AlloStim-8
BIOLOGICAL: AlloStim-8
BIOLOGICAL: AlloStim-8

Sponsor

Mirror Biologics, Inc.